Year archive

Marvel Biosciences Corp. — 2020 filings

All 24 regulatory filings released by Marvel Biosciences Corp. (MRVL) in 2020, sourced directly from the official regulator.

24 Filings

2020 Period

2020 filings (24)

Filing	Released	Lang
Other.pdf Regulatory Filings	2020-12-01	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2020-11-25	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2020-11-25	English
Interim MD&A - English.pdf Regulatory Filings	2020-11-25	English
Interim financial statements/report – English.pdf Regulatory Filings	2020-11-25	English
Material change report - English.pdf Regulatory Filings	2020-11-03	English
Other.pdf Regulatory Filings	2020-11-03	English
News release - English.pdf Regulatory Filings	2020-11-03	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2020-10-16	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2020-10-16	English
Annual MD&A - English.pdf Regulatory Filings	2020-10-16	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2020-10-16	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2020-10-16	English
Audited annual financial statements – English.pdf Regulatory Filings	2020-10-16	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2020-10-16	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2020-05-14	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2020-05-14	English
Interim MD&A - English.pdf Regulatory Filings	2020-05-14	English
Interim MD&A - English.pdf Regulatory Filings	2020-05-14	English
Interim financial statements/report – English.pdf Regulatory Filings	2020-05-14	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2020-03-10	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2020-03-10	English
Interim MD&A - English.pdf Regulatory Filings	2020-03-10	English
Interim financial statements/report – English.pdf Regulatory Filings	2020-03-10	English